These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7477581)

  • 41. Death and serious illness following influenza vaccination: a multidisciplinary investigation.
    Rue-Cover A; Iskander J; Lyn S; Burwen DR; Gargiullo P; Shadomy S; Blostein J; Bridges CB; Haber P; Satzger RD; Ball R; Seward JF
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):504-11. PubMed ID: 19373848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deaths following influenza vaccination--background mortality or causal connection?
    Kokia ES; Silverman BG; Green M; Kedem H; Guindy M; Shemer J
    Vaccine; 2007 Dec; 25(51):8557-61. PubMed ID: 18006121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allergic vasculitis and bronchial asthma following influenza vaccination].
    Reizis Z; Frank J; Sikuler E
    Harefuah; 1987 Jan; 112(2):70-1. PubMed ID: 3596383
    [No Abstract]   [Full Text] [Related]  

  • 44. [Acute meningoencephalitis immediately after an influenza vaccination].
    Froissart M; Mizon JP; Leroux JL
    Lille Med; 1978 Oct; 23(8):548-51. PubMed ID: 723420
    [No Abstract]   [Full Text] [Related]  

  • 45. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bilateral anterior ischemic optic neuropathy following influenza vaccination.
    Kawasaki A; Purvin VA; Tang R
    J Neuroophthalmol; 1998 Mar; 18(1):56-9. PubMed ID: 9532544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.
    Louie JK; Schechter R; Honarmand S; Guevara HF; Shoemaker TR; Madrigal NY; Woodfill CJ; Backer HD; Glaser CA
    Pediatrics; 2006 Apr; 117(4):e610-8. PubMed ID: 16585278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Difficulties in the diagnosis in the case of subacute paraplegia in a woman with Addison-Biermer disease].
    Szupień E; Ositek B; Pniewski J
    Neurol Neurochir Pol; 2004; 38(5):431-6. PubMed ID: 15565534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranasal influenza vaccine in a working population.
    Sendi P; Locher R; Bucheli B; Battegay M
    Clin Infect Dis; 2004 Apr; 38(7):974-80. PubMed ID: 15034829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.
    Müller D; Wutzler P; Szucs TD
    Med Klin (Munich); 2005 Jan; 100(1):6-13. PubMed ID: 15654537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of influenza immunization for inner-city children aged 6 to 23 months.
    Zimmerman RK; Hoberman A; Nowalk MP; Lin CJ; Greenberg DP; Weinberg ST; Bemm CW; Block B
    Am J Prev Med; 2004 Dec; 27(5):397-403. PubMed ID: 15556740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL
    Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy.
    Ring A; Marx G; Steer C; Prendiville J; Ellis P
    Int J Clin Pract; 2003; 57(6):542-3. PubMed ID: 12918895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neurologic diseases following influenza vaccination].
    Stöhr M; Mayer K
    Med Welt; 1976 May; 27(19):912-4. PubMed ID: 1272054
    [No Abstract]   [Full Text] [Related]  

  • 59. [Polyneuritis cranialis? Brain stem encephalitis and myelitis following preventive influenza vaccination].
    Buchner H; Ferbert A; Hündgen R
    Nervenarzt; 1988 Nov; 59(11):679-82. PubMed ID: 3211251
    [No Abstract]   [Full Text] [Related]  

  • 60. HSV2 reactivation and myelitis following influenza vaccination.
    Lieberman A; Curtis L
    Hum Vaccin Immunother; 2017 Mar; 13(3):572-573. PubMed ID: 27668461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.